NUTX Financials

Income Statement
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Revenue
216.5M
+42.7%
151.7M
-43.4%
267.8M
+9.8%
244.0M
+15.2%
211.8M
Cost of Revenue
0
0
0
0
0
Gross Profit
216.5M
+42.7%
151.7M
-43.4%
267.8M
+9.8%
244.0M
+15.2%
211.8M
Operating Expenses
135.2M
+12.0%
120.8M
-12.1%
137.4M
-34.6%
210.3M
+60.4%
131.1M
R&D
SG&A
51.9M
+196.7%
-53663000
-184.7%
63.3M
-50.3%
127.5M
+75.8%
72.5M
Operating Income
81.3M
+162.8%
30.9M
-76.3%
130.4M
+287.1%
33.7M
-58.2%
80.7M
EBITDA
86.8M
+140.3%
36.1M
-73.3%
135.4M
+247.8%
38.9M
-54.6%
85.8M
Net Income
62.8M
+277.9%
16.6M
-82.8%
96.8M
+499.6%
16.1M
-68.2%
50.8M
EPS (Basic)
$6.70
+301.2%
$1.67
-79.8%
$8.27
+380.3%
$-2.95
-178.9%
$3.74
EPS (Diluted)
$6.52
+307.5%
$1.60
-79.4%
$7.76
+363.1%
$-2.95
-188.6%
$3.33
Shares (Diluted)
7.2M
-3.0%
7.4M
+3.1%
7.2M
+19.7%
6.0M
-7.1%
6.5M
Nutex Health (NUTX) — Financials